As cell and gene therapies continue to revolutionize clinical practice, the quest for effective cell encapsulation and precise delivery methods becomes paramount. Recent strides, including the FDA’s approval of Lantrida™—a groundbreaking cell therapy for type 1 diabetes—and ongoing developments in solid tumor treatments, underscore the critical need for controlled delivery vehicles in cellular therapies.

Biocompatible polymers, such as alginates, are increasingly explored as a versatile platform to enhance therapeutic efficacy through controlled delivery.

In this panel discussion, we delve into the potential of cell encapsulation—a technique that holds promise for improving the survival, functionality, and effectiveness of transfected and transplanted cells. Our focus extends to the key characteristics of ultrapure biopolymers, which play a crucial role in ensuring cell viability, biocompatibility, and controlled delivery. Moreover, we address the critical aspects of scalability and reproducibility in polymer-based encapsulation systems, essential for translating research breakthroughs into practical clinical applications. Join our expert panel as we unlock the potential of polymer-based encapsulation, propelling cellular therapies into a new era of precision and efficacy.

• Explore considerations for animal-free polymers that support cell growth and delivery
• Understand the characteristics of polymers that seamlessly transition from research to clinical application
• Gain insights into overcoming cell therapy delivery challenges and potential solutions
• Discover why alginates serve as suitable polymers for cell cultures, transfection, encapsulation, and implantation